Dinesh B. Bedathuru (he/him/his)

Principal Scientist
Vantage Research Inc

Poster(s):

• (S-017) Optimal therapeutic combinations for Phase 3 UC trial design- recommendations from a QSP platform model
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT

• (T-008) Model-informed dose priming strategy for T cell engagers: Leveraging early clinical data to mitigate CRS
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT